40 active shortage notices across 11 countries · 7 anticipated.
Last updated 1 Nov 2026 · sourced from official medicines regulators
| New Zealand | high | 9 | 2 Jul 2025 | — | Pharmac |
| Thailand | high | 6 | 4 Oct 2022 | — | NDI-TH |
| United Kingdom | high | 1 | 1 Aug 2024 | 30 Nov 2024 | MHRA |
| European Union | high | 1 | 6 May 2024 | — | EMA |
| Netherlands | medium | 6 | 17 Mar 2026 | — | CBG-MEB |
| Canada | medium | 3 | 10 Mar 2017 | — | HC |
| India | medium | 2 | 1 Aug 2026 | — | CDSCO |
| United States | medium | 2 | 25 Oct 2022 | — | FDA |
| Belgium | medium | 1 | 21 Aug 2026 | 9 Oct 2026 | FAMHP |
| Peru | medium | 1 | 1 Jan 2021 | 31 Dec 2021 | DIGEMID |
Yes. As of the latest regulator updates, Salbutamol has 40 active shortage notices across 11 countries (Australia, New Zealand, Thailand, United Kingdom, European Union, Netherlands and more). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Salbutamol shortages to supply-chain disruption, manufacturing problems, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 31 Dec 2021 to 31 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Albuterol Sulfate · Albuterol Sulfate Inhalation Solution · Albuterol · Clenbuterol
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.